lorazepam has been researched along with perphenazine in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 6 (50.00) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Baron, DH; Ciraulo, DA; Sands, BF; Shader, RI | 1 |
Caruana, RJ; Dilworth, LR; Williford, PM | 1 |
Silva, RG; Tolstunov, L | 1 |
Cheng, DC; Katz, J; Kavanagh, BP; Saccomanno, PM; Sandler, AN | 1 |
1 review(s) available for lorazepam and perphenazine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lorazepam and perphenazine
Article | Year |
---|---|
Comparison of lorazepam alone vs lorazepam, morphine, and perphenazine for cardiac premedication.
Topics: Aged; Anti-Anxiety Agents; Double-Blind Method; Female; Hemodynamics; Hemoglobins; Humans; Lorazepam; Male; Middle Aged; Morphine; Myocardial Ischemia; Perphenazine; Preanesthetic Medication; Prospective Studies; Respiration | 1997 |
10 other study(ies) available for lorazepam and perphenazine
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
The diagnosis and treatment of panic disorder in alcoholics: three cases.
Topics: Adult; Alcohol Drinking; Alcoholism; Anxiety Disorders; Clonazepam; Diazepam; Follow-Up Studies; Humans; Lactates; Lactic Acid; Lorazepam; Male; Middle Aged; Panic; Perphenazine | 1990 |
Acute rhabdomyolysis associated with an overdose of lorazepam, perphenazine and amitriptyline.
Topics: Adult; Amitriptyline; Anti-Anxiety Agents; Female; Humans; Lorazepam; Myoglobinuria; Myositis; Perphenazine | 1983 |
Steroid-induced psychosis: report of case.
Topics: Dexamethasone; Edema; Haloperidol; Humans; Lorazepam; Male; Maxilla; Middle Aged; Osteotomy; Perphenazine; Psychoses, Substance-Induced | 1995 |